ProCE Banner Activity

European Perspective and Application of New Clinical Data for Ovarian Cancer and Recent Approvals in Endometrial Cancers

Conference Coverage
Clinical Thought

Read this commentary from Prof Nicole Concin, MD, PhD, on the application of new clinical data for ovarian and endometrial cancer.

This ClinicalThought is intended for healthcare professionals practicing medicine outside of the United States.

Released: December 07, 2021

Expiration: December 06, 2022

No longer available for credit.

Share

Faculty

Nicole Concin

Nicole Concin, MD, PhD

Professor
Department of Gynaecology and Obstetrics
Medical University Innsbruck
Innsbruck, Austria
Consultant in Gynaecological Oncology
Department of Gynaecology and Gynaecologocial Oncology
KEM Evang. Kliniken Essen-Mitte
Essen, Germany

Supporters

This educational activity is supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Nicole Concin, MD, PhD

Professor
Department of Gynaecology and Obstetrics
Medical University Innsbruck
Innsbruck, Austria
Consultant in Gynaecological Oncology
Department of Gynaecology and Gynaecologocial Oncology
KEM Evang. Kliniken Essen-Mitte
Essen, Germany

Prof Nicole Concin, MD, PhD, has disclosed that she has received consulting fees from Akesobio, AstraZeneca, Eisai, eTheRNA, GlaxoSmithKline, Mersana, and Seagen and fees for non-CME/CE services from Amgen, Genmab, MSD, and Roche.